ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Development of Dimethylsulfonium Probes for Broad Profiling of Methyllysine Reader Proteins.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of Dimethylsulfonium Probes for Broad Profiling of Methyllysine Reader Proteins.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Lysine methylation is a crucial post-translational modification regulating various cellular processes. Reader proteins recognize specific methylated proteins as key mediators for the biological function of lysine methylation. Due to a correlation between reader activity and cell signaling of disorders, readers serve as attractive therapeutic targets. Despite proteomic advances identifying thousands of methylation sites, far fewer methyllysine readers have been characterized. Current research relies exclusively on site-specific probes, which are restricted to individual sites but incapable of global profiling. Here, an oligoglycine-based dimethylsulfonium peptide is reported as a general probe that is capable of binding and crosslinking to readers without bias toward particular sites or domains. The general reactivity to methyllysine readers in vitro is first demonstrated. The probe to cell nuclei is next applied, and the general probe enables identification of site-specific readers by methyllysine peptide competition. In addition, the probe shows the potential for assessment of reader inhibitor activity and selectivity. Furthermore, bioinformatic analysis is performed to predict potential readers in the human genome, and global profiling of the potential readers in the nuclear proteome was achieved using the general probe. Thus, such a sulfonium probe provides a novel tool for global reader profiling, complementing the site-specific probes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.